Jason Chou, PharmD, Ochsner Health’s vice president of pharmacy services, recently told Becker’s he’s concerned about dobutamine, which is experiencing manufacturing issues.
“Dobutamine has been a challenge off-and-on and that’s a very important drug for the treatment of heart failure patients with not a lot of other alternatives,” Dr. Chou said.
The agency’s report on current and resolved drug shortages, which is updated daily, includes seven more drugs on backlog than its list in June contained. On Jan. 11, 114 drugs were in shortage.
The most recent drugs in shortage include oxytocin injection, which is used during labor, and fludarabine phosphate injection, a treatment for adult patients with B-cell chronic lymphocytic leukemia.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
